| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.07 |